放射性医薬品溶液のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Radiopharmaceutical Solutions Market Insights, Forecast to 2028

• レポートコード：QY2203B13739 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の放射性医薬品溶液の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に放射性医薬品溶液の世界市場のxxx％を占める「オーラルトラッキング」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の放射性医薬品溶液の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの放射性医薬品溶液市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの放射性医薬品溶液市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 放射性医薬品溶液のグローバル主要メーカーには、IBA、GE Healthcare、Actinium Pharmaceuticals、Alseres Pharmaceuticals、Cardinal Health、Jubilant Pharma、Central Research Laboratories、Cyclomedica、Bracco、Eckert & Ziegler Radiopharma、などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 放射性医薬品溶液市場は、種類と用途によって区分されます。世界の放射性医薬品溶液市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 オーラルトラッキング、ヴィーントラッキング 【用途別セグメント】 病院、医療システム、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 放射性医薬品溶液製品概要 - 種類別市場（オーラルトラッキング、ヴィーントラッキング） - 用途別市場（病院、医療システム、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の放射性医薬品溶液販売量予測2017-2028 - 世界の放射性医薬品溶液売上予測2017-2028 - 放射性医薬品溶液の地域別販売量 - 放射性医薬品溶液の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別放射性医薬品溶液販売量 - 主要メーカー別放射性医薬品溶液売上 - 主要メーカー別放射性医薬品溶液価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（オーラルトラッキング、ヴィーントラッキング） - 放射性医薬品溶液の種類別販売量 - 放射性医薬品溶液の種類別売上 - 放射性医薬品溶液の種類別価格 ・用途別市場規模（病院、医療システム、その他） - 放射性医薬品溶液の用途別販売量 - 放射性医薬品溶液の用途別売上 - 放射性医薬品溶液の用途別価格 ・北米市場 - 北米の放射性医薬品溶液市場規模（種類別、用途別） - 主要国別の放射性医薬品溶液市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの放射性医薬品溶液市場規模（種類別、用途別） - 主要国別の放射性医薬品溶液市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の放射性医薬品溶液市場規模（種類別、用途別） - 主要国別の放射性医薬品溶液市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の放射性医薬品溶液市場規模（種類別、用途別） - 主要国別の放射性医薬品溶液市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの放射性医薬品溶液市場規模（種類別、用途別） - 主要国別の放射性医薬品溶液市場規模（トルコ、サウジアラビア） ・企業情報 IBA、GE Healthcare、Actinium Pharmaceuticals、Alseres Pharmaceuticals、Cardinal Health、Jubilant Pharma、Central Research Laboratories、Cyclomedica、Bracco、Eckert & Ziegler Radiopharma、 ・産業チェーン及び販売チャネル分析 - 放射性医薬品溶液の産業チェーン分析 - 放射性医薬品溶液の原材料 - 放射性医薬品溶液の生産プロセス - 放射性医薬品溶液の販売及びマーケティング - 放射性医薬品溶液の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 放射性医薬品溶液の産業動向 - 放射性医薬品溶液のマーケットドライバー - 放射性医薬品溶液の課題 - 放射性医薬品溶液の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Radiopharmaceutical Solutions Market

The global Radiopharmaceutical Solutions market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Oral Tracking accounting for % of the Radiopharmaceutical Solutions global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Radiopharmaceutical Solutions market size is valued at US$ million in 2021, while the North America and Europe Radiopharmaceutical Solutions are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Radiopharmaceutical Solutions landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Radiopharmaceutical Solutions market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Radiopharmaceutical Solutions market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Radiopharmaceutical Solutions market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Radiopharmaceutical Solutions market.

Global Radiopharmaceutical Solutions Scope and Market Size

Radiopharmaceutical Solutions market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Radiopharmaceutical Solutions market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Oral Tracking

Vein Tracking

Segment by Application

Hospitals

Health Systems

Others

By Company

IBA

GE Healthcare

Actinium Pharmaceuticals

Alseres Pharmaceuticals

Cardinal Health

Jubilant Pharma

Central Research Laboratories

Cyclomedica

Bracco

Eckert & Ziegler Radiopharma

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

レポート目次

---

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Radiopharmaceutical Solutions Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Oral Tracking

1.2.3 Vein Tracking

1.3 Market by Application

1.3.1 Global Radiopharmaceutical Solutions Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Health Systems

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Radiopharmaceutical Solutions Market Perspective (2017-2028)

2.2 Radiopharmaceutical Solutions Growth Trends by Region

2.2.1 Radiopharmaceutical Solutions Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Radiopharmaceutical Solutions Historic Market Size by Region (2017-2022)

2.2.3 Radiopharmaceutical Solutions Forecasted Market Size by Region (2023-2028)

2.3 Radiopharmaceutical Solutions Market Dynamics

2.3.1 Radiopharmaceutical Solutions Industry Trends

2.3.2 Radiopharmaceutical Solutions Market Drivers

2.3.3 Radiopharmaceutical Solutions Market Challenges

2.3.4 Radiopharmaceutical Solutions Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Radiopharmaceutical Solutions Players by Revenue

3.1.1 Global Top Radiopharmaceutical Solutions Players by Revenue (2017-2022)

3.1.2 Global Radiopharmaceutical Solutions Revenue Market Share by Players (2017-2022)

3.2 Global Radiopharmaceutical Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Radiopharmaceutical Solutions Revenue

3.4 Global Radiopharmaceutical Solutions Market Concentration Ratio

3.4.1 Global Radiopharmaceutical Solutions Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical Solutions Revenue in 2021

3.5 Radiopharmaceutical Solutions Key Players Head office and Area Served

3.6 Key Players Radiopharmaceutical Solutions Product Solution and Service

3.7 Date of Enter into Radiopharmaceutical Solutions Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Radiopharmaceutical Solutions Breakdown Data by Type

4.1 Global Radiopharmaceutical Solutions Historic Market Size by Type (2017-2022)

4.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Type (2023-2028)

5 Radiopharmaceutical Solutions Breakdown Data by Application

5.1 Global Radiopharmaceutical Solutions Historic Market Size by Application (2017-2022)

5.2 Global Radiopharmaceutical Solutions Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Radiopharmaceutical Solutions Market Size (2017-2028)

6.2 North America Radiopharmaceutical Solutions Market Size by Type

6.2.1 North America Radiopharmaceutical Solutions Market Size by Type (2017-2022)

6.2.2 North America Radiopharmaceutical Solutions Market Size by Type (2023-2028)

6.2.3 North America Radiopharmaceutical Solutions Market Share by Type (2017-2028)

6.3 North America Radiopharmaceutical Solutions Market Size by Application

6.3.1 North America Radiopharmaceutical Solutions Market Size by Application (2017-2022)

6.3.2 North America Radiopharmaceutical Solutions Market Size by Application (2023-2028)

6.3.3 North America Radiopharmaceutical Solutions Market Share by Application (2017-2028)

6.4 North America Radiopharmaceutical Solutions Market Size by Country

6.4.1 North America Radiopharmaceutical Solutions Market Size by Country (2017-2022)

6.4.2 North America Radiopharmaceutical Solutions Market Size by Country (2023-2028)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Radiopharmaceutical Solutions Market Size (2017-2028)

7.2 Europe Radiopharmaceutical Solutions Market Size by Type

7.2.1 Europe Radiopharmaceutical Solutions Market Size by Type (2017-2022)

7.2.2 Europe Radiopharmaceutical Solutions Market Size by Type (2023-2028)

7.2.3 Europe Radiopharmaceutical Solutions Market Share by Type (2017-2028)

7.3 Europe Radiopharmaceutical Solutions Market Size by Application

7.3.1 Europe Radiopharmaceutical Solutions Market Size by Application (2017-2022)

7.3.2 Europe Radiopharmaceutical Solutions Market Size by Application (2023-2028)

7.3.3 Europe Radiopharmaceutical Solutions Market Share by Application (2017-2028)

7.4 Europe Radiopharmaceutical Solutions Market Size by Country

7.4.1 Europe Radiopharmaceutical Solutions Market Size by Country (2017-2022)

7.4.2 Europe Radiopharmaceutical Solutions Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Radiopharmaceutical Solutions Market Size (2017-2028)

8.2 Asia-Pacific Radiopharmaceutical Solutions Market Size by Type

8.2.1 Asia-Pacific Radiopharmaceutical Solutions Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Radiopharmaceutical Solutions Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Radiopharmaceutical Solutions Market Share by Type (2017-2028)

8.3 Asia-Pacific Radiopharmaceutical Solutions Market Size by Application

8.3.1 Asia-Pacific Radiopharmaceutical Solutions Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Radiopharmaceutical Solutions Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Radiopharmaceutical Solutions Market Share by Application (2017-2028)

8.4 Asia-Pacific Radiopharmaceutical Solutions Market Size by Region

8.4.1 Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Radiopharmaceutical Solutions Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Radiopharmaceutical Solutions Market Size (2017-2028)

9.2 Latin America Radiopharmaceutical Solutions Market Size by Type

9.2.1 Latin America Radiopharmaceutical Solutions Market Size by Type (2017-2022)

9.2.2 Latin America Radiopharmaceutical Solutions Market Size by Type (2023-2028)

9.2.3 Latin America Radiopharmaceutical Solutions Market Share by Type (2017-2028)

9.3 Latin America Radiopharmaceutical Solutions Market Size by Application

9.3.1 Latin America Radiopharmaceutical Solutions Market Size by Application (2017-2022)

9.3.2 Latin America Radiopharmaceutical Solutions Market Size by Application (2023-2028)

9.3.3 Latin America Radiopharmaceutical Solutions Market Share by Application (2017-2028)

9.4 Latin America Radiopharmaceutical Solutions Market Size by Country

9.4.1 Latin America Radiopharmaceutical Solutions Market Size by Country (2017-2022)

9.4.2 Latin America Radiopharmaceutical Solutions Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Radiopharmaceutical Solutions Market Size (2017-2028)

10.2 Middle East & Africa Radiopharmaceutical Solutions Market Size by Type

10.2.1 Middle East & Africa Radiopharmaceutical Solutions Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Radiopharmaceutical Solutions Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Radiopharmaceutical Solutions Market Share by Type (2017-2028)

10.3 Middle East & Africa Radiopharmaceutical Solutions Market Size by Application

10.3.1 Middle East & Africa Radiopharmaceutical Solutions Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Radiopharmaceutical Solutions Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Radiopharmaceutical Solutions Market Share by Application (2017-2028)

10.4 Middle East & Africa Radiopharmaceutical Solutions Market Size by Country

10.4.1 Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Radiopharmaceutical Solutions Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 IBA

11.1.1 IBA Company Details

11.1.2 IBA Business Overview

11.1.3 IBA Radiopharmaceutical Solutions Introduction

11.1.4 IBA Revenue in Radiopharmaceutical Solutions Business (2017-2022)

11.1.5 IBA Recent Developments

11.2 GE Healthcare

11.2.1 GE Healthcare Company Details

11.2.2 GE Healthcare Business Overview

11.2.3 GE Healthcare Radiopharmaceutical Solutions Introduction

11.2.4 GE Healthcare Revenue in Radiopharmaceutical Solutions Business (2017-2022)

11.2.5 GE Healthcare Recent Developments

11.3 Actinium Pharmaceuticals

11.3.1 Actinium Pharmaceuticals Company Details

11.3.2 Actinium Pharmaceuticals Business Overview

11.3.3 Actinium Pharmaceuticals Radiopharmaceutical Solutions Introduction

11.3.4 Actinium Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2017-2022)

11.3.5 Actinium Pharmaceuticals Recent Developments

11.4 Alseres Pharmaceuticals

11.4.1 Alseres Pharmaceuticals Company Details

11.4.2 Alseres Pharmaceuticals Business Overview

11.4.3 Alseres Pharmaceuticals Radiopharmaceutical Solutions Introduction

11.4.4 Alseres Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2017-2022)

11.4.5 Alseres Pharmaceuticals Recent Developments

11.5 Cardinal Health

11.5.1 Cardinal Health Company Details

11.5.2 Cardinal Health Business Overview

11.5.3 Cardinal Health Radiopharmaceutical Solutions Introduction

11.5.4 Cardinal Health Revenue in Radiopharmaceutical Solutions Business (2017-2022)

11.5.5 Cardinal Health Recent Developments

11.6 Jubilant Pharma

11.6.1 Jubilant Pharma Company Details

11.6.2 Jubilant Pharma Business Overview

11.6.3 Jubilant Pharma Radiopharmaceutical Solutions Introduction

11.6.4 Jubilant Pharma Revenue in Radiopharmaceutical Solutions Business (2017-2022)

11.6.5 Jubilant Pharma Recent Developments

11.7 Central Research Laboratories

11.7.1 Central Research Laboratories Company Details

11.7.2 Central Research Laboratories Business Overview

11.7.3 Central Research Laboratories Radiopharmaceutical Solutions Introduction

11.7.4 Central Research Laboratories Revenue in Radiopharmaceutical Solutions Business (2017-2022)

11.7.5 Central Research Laboratories Recent Developments

11.8 Cyclomedica

11.8.1 Cyclomedica Company Details

11.8.2 Cyclomedica Business Overview

11.8.3 Cyclomedica Radiopharmaceutical Solutions Introduction

11.8.4 Cyclomedica Revenue in Radiopharmaceutical Solutions Business (2017-2022)

11.8.5 Cyclomedica Recent Developments

11.9 Bracco

11.9.1 Bracco Company Details

11.9.2 Bracco Business Overview

11.9.3 Bracco Radiopharmaceutical Solutions Introduction

11.9.4 Bracco Revenue in Radiopharmaceutical Solutions Business (2017-2022)

11.9.5 Bracco Recent Developments

11.10 Eckert & Ziegler Radiopharma

11.10.1 Eckert & Ziegler Radiopharma Company Details

11.10.2 Eckert & Ziegler Radiopharma Business Overview

11.10.3 Eckert & Ziegler Radiopharma Radiopharmaceutical Solutions Introduction

11.10.4 Eckert & Ziegler Radiopharma Revenue in Radiopharmaceutical Solutions Business (2017-2022)

11.10.5 Eckert & Ziegler Radiopharma Recent Developments

12 Analyst’s Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Radiopharmaceutical Solutions Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Oral Tracking

Table 3. Key Players of Vein Tracking

Table 4. Global Radiopharmaceutical Solutions Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 5. Global Radiopharmaceutical Solutions Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 6. Global Radiopharmaceutical Solutions Market Size by Region (2017-2022) & (US$ Million)

Table 7. Global Radiopharmaceutical Solutions Market Share by Region (2017-2022)

Table 8. Global Radiopharmaceutical Solutions Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 9. Global Radiopharmaceutical Solutions Market Share by Region (2023-2028)

Table 10. Radiopharmaceutical Solutions Market Trends

Table 11. Radiopharmaceutical Solutions Market Drivers

Table 12. Radiopharmaceutical Solutions Market Challenges

Table 13. Radiopharmaceutical Solutions Market Restraints

Table 14. Global Radiopharmaceutical Solutions Revenue by Players (2017-2022) & (US$ Million)

Table 15. Global Radiopharmaceutical Solutions Revenue Share by Players (2017-2022)

Table 16. Global Top Radiopharmaceutical Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Solutions as of 2021)

Table 17. Ranking of Global Top Radiopharmaceutical Solutions Companies by Revenue (US$ Million) in 2021

Table 18. Global 5 Largest Players Market Share by Radiopharmaceutical Solutions Revenue (CR5 and HHI) & (2017-2022)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Radiopharmaceutical Solutions Product Solution and Service

Table 21. Date of Enter into Radiopharmaceutical Solutions Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Radiopharmaceutical Solutions Market Size by Type (2017-2022) & (US$ Million)

Table 24. Global Radiopharmaceutical Solutions Revenue Market Share by Type (2017-2022)

Table 25. Global Radiopharmaceutical Solutions Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 26. Global Radiopharmaceutical Solutions Revenue Market Share by Type (2023-2028)

Table 27. Global Radiopharmaceutical Solutions Market Size by Application (2017-2022) & (US$ Million)

Table 28. Global Radiopharmaceutical Solutions Revenue Share by Application (2017-2022)

Table 29. Global Radiopharmaceutical Solutions Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 30. Global Radiopharmaceutical Solutions Revenue Share by Application (2023-2028)

Table 31. North America Radiopharmaceutical Solutions Market Size by Type (2017-2022) & (US$ Million)

Table 32. North America Radiopharmaceutical Solutions Market Size by Type (2023-2028) & (US$ Million)

Table 33. North America Radiopharmaceutical Solutions Market Size by Application (2017-2022) & (US$ Million)

Table 34. North America Radiopharmaceutical Solutions Market Size by Application (2023-2028) & (US$ Million)

Table 35. North America Radiopharmaceutical Solutions Market Size by Country (2017-2022) & (US$ Million)

Table 36. North America Radiopharmaceutical Solutions Market Size by Country (2023-2028) & (US$ Million)

Table 37. Europe Radiopharmaceutical Solutions Market Size by Type (2017-2022) & (US$ Million)

Table 38. Europe Radiopharmaceutical Solutions Market Size by Type (2023-2028) & (US$ Million)

Table 39. Europe Radiopharmaceutical Solutions Market Size by Application (2017-2022) & (US$ Million)

Table 40. Europe Radiopharmaceutical Solutions Market Size by Application (2023-2028) & (US$ Million)

Table 41. Europe Radiopharmaceutical Solutions Market Size by Country (2017-2022) & (US$ Million)

Table 42. Europe Radiopharmaceutical Solutions Market Size by Country (2023-2028) & (US$ Million)

Table 43. Asia Pacific Radiopharmaceutical Solutions Market Size by Type (2017-2022) & (US$ Million)

Table 44. Asia Pacific Radiopharmaceutical Solutions Market Size by Type (2023-2028) & (US$ Million)

Table 45. Asia Pacific Radiopharmaceutical Solutions Market Size by Application (2017-2022) & (US$ Million)

Table 46. Asia Pacific Radiopharmaceutical Solutions Market Size by Application (2023-2028) & (US$ Million)

Table 47. Asia Pacific Radiopharmaceutical Solutions Market Size by Region (2017-2022) & (US$ Million)

Table 48. Asia Pacific Radiopharmaceutical Solutions Market Size by Region (2023-2028) & (US$ Million)

Table 49. Latin America Radiopharmaceutical Solutions Market Size by Type (2017-2022) & (US$ Million)

Table 50. Latin America Radiopharmaceutical Solutions Market Size by Type (2023-2028) & (US$ Million)

Table 51. Latin America Radiopharmaceutical Solutions Market Size by Application (2017-2022) & (US$ Million)

Table 52. Latin America Radiopharmaceutical Solutions Market Size by Application (2023-2028) & (US$ Million)

Table 53. Latin America Radiopharmaceutical Solutions Market Size by Country (2017-2022) & (US$ Million)

Table 54. Latin America Radiopharmaceutical Solutions Market Size by Country (2023-2028) & (US$ Million)

Table 55. Middle East and Africa Radiopharmaceutical Solutions Market Size by Type (2017-2022) & (US$ Million)

Table 56. Middle East and Africa Radiopharmaceutical Solutions Market Size by Type (2023-2028) & (US$ Million)

Table 57. Middle East and Africa Radiopharmaceutical Solutions Market Size by Application (2017-2022) & (US$ Million)

Table 58. Middle East and Africa Radiopharmaceutical Solutions Market Size by Application (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Radiopharmaceutical Solutions Market Size by Country (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Radiopharmaceutical Solutions Market Size by Country (2023-2028) & (US$ Million)

Table 61. IBA Company Details

Table 62. IBA Business Overview

Table 63. IBA Radiopharmaceutical Solutions Product

Table 64. IBA Revenue in Radiopharmaceutical Solutions Business (2017-2022) & (US$ Million)

Table 65. IBA Recent Developments

Table 66. GE Healthcare Company Details

Table 67. GE Healthcare Business Overview

Table 68. GE Healthcare Radiopharmaceutical Solutions Product

Table 69. GE Healthcare Revenue in Radiopharmaceutical Solutions Business (2017-2022) & (US$ Million)

Table 70. GE Healthcare Recent Developments

Table 71. Actinium Pharmaceuticals Company Details

Table 72. Actinium Pharmaceuticals Business Overview

Table 73. Actinium Pharmaceuticals Radiopharmaceutical Solutions Product

Table 74. Actinium Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2017-2022) & (US$ Million)

Table 75. Actinium Pharmaceuticals Recent Developments

Table 76. Alseres Pharmaceuticals Company Details

Table 77. Alseres Pharmaceuticals Business Overview

Table 78. Alseres Pharmaceuticals Radiopharmaceutical Solutions Product

Table 79. Alseres Pharmaceuticals Revenue in Radiopharmaceutical Solutions Business (2017-2022) & (US$ Million)

Table 80. Alseres Pharmaceuticals Recent Developments

Table 81. Cardinal Health Company Details

Table 82. Cardinal Health Business Overview

Table 83. Cardinal Health Radiopharmaceutical Solutions Product

Table 84. Cardinal Health Revenue in Radiopharmaceutical Solutions Business (2017-2022) & (US$ Million)

Table 85. Cardinal Health Recent Developments

Table 86. Jubilant Pharma Company Details

Table 87. Jubilant Pharma Business Overview

Table 88. Jubilant Pharma Radiopharmaceutical Solutions Product

Table 89. Jubilant Pharma Revenue in Radiopharmaceutical Solutions Business (2017-2022) & (US$ Million)

Table 90. Jubilant Pharma Recent Developments

Table 91. Central Research Laboratories Company Details

Table 92. Central Research Laboratories Business Overview

Table 93. Central Research Laboratories Radiopharmaceutical Solutions Product

Table 94. Central Research Laboratories Revenue in Radiopharmaceutical Solutions Business (2017-2022) & (US$ Million)

Table 95. Central Research Laboratories Recent Developments

Table 96. Cyclomedica Company Details

Table 97. Cyclomedica Business Overview

Table 98. Cyclomedica Radiopharmaceutical Solutions Product

Table 99. Cyclomedica Revenue in Radiopharmaceutical Solutions Business (2017-2022) & (US$ Million)

Table 100. Cyclomedica Recent Developments

Table 101. Bracco Company Details

Table 102. Bracco Business Overview

Table 103. Bracco Radiopharmaceutical Solutions Product

Table 104. Bracco Revenue in Radiopharmaceutical Solutions Business (2017-2022) & (US$ Million)

Table 105. Bracco Recent Developments

Table 106. Eckert & Ziegler Radiopharma Company Details

Table 107. Eckert & Ziegler Radiopharma Business Overview

Table 108. Eckert & Ziegler Radiopharma Radiopharmaceutical Solutions Product

Table 109. Eckert & Ziegler Radiopharma Revenue in Radiopharmaceutical Solutions Business (2017-2022) & (US$ Million)

Table 110. Eckert & Ziegler Radiopharma Recent Developments

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Radiopharmaceutical Solutions Market Share by Type: 2021 VS 2028

Figure 2. Oral Tracking Features

Figure 3. Vein Tracking Features

Figure 4. Global Radiopharmaceutical Solutions Market Share by Application: 2021 VS 2028

Figure 5. Hospitals Case Studies

Figure 6. Health Systems Case Studies

Figure 7. Others Case Studies

Figure 8. Radiopharmaceutical Solutions Report Years Considered

Figure 9. Global Radiopharmaceutical Solutions Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 10. Global Radiopharmaceutical Solutions Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global Radiopharmaceutical Solutions Market Share by Region: 2021 VS 2028

Figure 12. Global Radiopharmaceutical Solutions Market Share by Players in 2021

Figure 13. Global Top Radiopharmaceutical Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Solutions as of 2021)

Figure 14. The Top 10 and 5 Players Market Share by Radiopharmaceutical Solutions Revenue in 2021

Figure 15. North America Radiopharmaceutical Solutions Market Size YoY (2017-2028) & (US$ Million)

Figure 16. North America Radiopharmaceutical Solutions Market Size Market Share by Type (2017-2028)

Figure 17. North America Radiopharmaceutical Solutions Market Size Market Share by Application (2017-2028)

Figure 18. North America Radiopharmaceutical Solutions Market Size Share by Country (2017-2028)

Figure 19. United States Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 20. Canada Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Europe Radiopharmaceutical Solutions Market Size YoY (2017-2028) & (US$ Million)

Figure 22. Europe Radiopharmaceutical Solutions Market Size Market Share by Type (2017-2028)

Figure 23. Europe Radiopharmaceutical Solutions Market Size Market Share by Application (2017-2028)

Figure 24. Europe Radiopharmaceutical Solutions Market Size Share by Country (2017-2028)

Figure 25. Germany Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 26. France Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. U.K. Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. Italy Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Russia Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Nordic Countries Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Asia-Pacific Radiopharmaceutical Solutions Market Size YoY (2017-2028) & (US$ Million)

Figure 32. Asia Pacific Radiopharmaceutical Solutions Market Size Market Share by Type (2017-2028)

Figure 33. Asia Pacific Radiopharmaceutical Solutions Market Size Market Share by Application (2017-2028)

Figure 34. Asia Pacific Radiopharmaceutical Solutions Market Size Share by Region (2017-2028)

Figure 35. China Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 36. Japan Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. South Korea Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Southeast Asia Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. India Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Australia Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 41. Latin America Radiopharmaceutical Solutions Market Size YoY (2017-2028) & (US$ Million)

Figure 42. Latin America Radiopharmaceutical Solutions Market Size Market Share by Type (2017-2028)

Figure 43. Latin America Radiopharmaceutical Solutions Market Size Market Share by Application (2017-2028)

Figure 44. Latin America Radiopharmaceutical Solutions Market Size Share by Country (2017-2028)

Figure 45. Mexico Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 46. Brazil Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 47. Middle East & Africa Radiopharmaceutical Solutions Market Size YoY (2017-2028) & (US$ Million)

Figure 48. Middle East and Africa Radiopharmaceutical Solutions Market Size Market Share by Type (2017-2028)

Figure 49. Middle East and Africa Radiopharmaceutical Solutions Market Size Market Share by Application (2017-2028)

Figure 50. Middle East and Africa Radiopharmaceutical Solutions Market Size Share by Country (2017-2028)

Figure 51. Turkey Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 52. Saudi Arabia Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 53. UAE Radiopharmaceutical Solutions Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. IBA Revenue Growth Rate in Radiopharmaceutical Solutions Business (2017-2022)

Figure 55. GE Healthcare Revenue Growth Rate in Radiopharmaceutical Solutions Business (2017-2022)

Figure 56. Actinium Pharmaceuticals Revenue Growth Rate in Radiopharmaceutical Solutions Business (2017-2022)

Figure 57. Alseres Pharmaceuticals Revenue Growth Rate in Radiopharmaceutical Solutions Business (2017-2022)

Figure 58. Cardinal Health Revenue Growth Rate in Radiopharmaceutical Solutions Business (2017-2022)

Figure 59. Jubilant Pharma Revenue Growth Rate in Radiopharmaceutical Solutions Business (2017-2022)

Figure 60. Central Research Laboratories Revenue Growth Rate in Radiopharmaceutical Solutions Business (2017-2022)

Figure 61. Cyclomedica Revenue Growth Rate in Radiopharmaceutical Solutions Business (2017-2022)

Figure 62. Bracco Revenue Growth Rate in Radiopharmaceutical Solutions Business (2017-2022)

Figure 63. Eckert & Ziegler Radiopharma Revenue Growth Rate in Radiopharmaceutical Solutions Business (2017-2022)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

---